IL123258A - PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - Google Patents
PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEInfo
- Publication number
- IL123258A IL123258A IL12325896A IL12325896A IL123258A IL 123258 A IL123258 A IL 123258A IL 12325896 A IL12325896 A IL 12325896A IL 12325896 A IL12325896 A IL 12325896A IL 123258 A IL123258 A IL 123258A
- Authority
- IL
- Israel
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- opioid receptors
- peptides selective
- Prior art date
Links
- 102000051367 mu Opioid Receptors Human genes 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108020001612 μ-opioid receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502877A SE9502877D0 (sv) | 1995-08-18 | 1995-08-18 | Novel opioid peptides |
| SE9503924A SE9503924D0 (sv) | 1995-08-18 | 1995-11-07 | Novel opioid peptides |
| PCT/SE1996/001011 WO1997007130A1 (en) | 1995-08-18 | 1996-08-14 | Novel opioid peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL123258A0 IL123258A0 (en) | 1998-09-24 |
| IL123258A true IL123258A (en) | 2003-03-12 |
Family
ID=26662362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12325896A IL123258A (en) | 1995-08-18 | 1996-08-14 | PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6337319B1 (da) |
| EP (1) | EP0845003B1 (da) |
| JP (1) | JPH11512086A (da) |
| KR (1) | KR19990037677A (da) |
| CN (1) | CN1200127A (da) |
| AR (1) | AR003475A1 (da) |
| AT (1) | ATE210148T1 (da) |
| AU (1) | AU711862B2 (da) |
| BR (1) | BR9610248A (da) |
| CA (1) | CA2229797A1 (da) |
| CZ (1) | CZ287299B6 (da) |
| DE (1) | DE69617699T2 (da) |
| DK (1) | DK0845003T3 (da) |
| EE (1) | EE9800048A (da) |
| ES (1) | ES2171224T3 (da) |
| HU (1) | HUP9901209A3 (da) |
| IL (1) | IL123258A (da) |
| IS (1) | IS4664A (da) |
| NO (1) | NO980592L (da) |
| NZ (1) | NZ315809A (da) |
| PL (1) | PL325113A1 (da) |
| RU (1) | RU2165432C2 (da) |
| SE (1) | SE9503924D0 (da) |
| SK (1) | SK282469B6 (da) |
| TR (1) | TR199800258T1 (da) |
| TW (1) | TW424095B (da) |
| WO (1) | WO1997007130A1 (da) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030032774A1 (en) * | 1994-02-21 | 2003-02-13 | Astrazeneca Ab | Novel opioid peptides for the treatment of pain |
| US5885958A (en) * | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
| SE9701718D0 (sv) * | 1997-05-07 | 1997-05-07 | Astra Ab | Analgesic peptidomimetic compounds |
| SE9800865D0 (sv) * | 1998-03-16 | 1998-03-16 | Astra Ab | New Process |
| WO2001013938A1 (fr) * | 1999-08-25 | 2001-03-01 | Daiichi Fine Chemical Co., Ltd. | Composition therapeutique pouvant etre administree par voie percutanee ou par les muqueuses |
| AU1623801A (en) * | 1999-11-19 | 2001-05-30 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
| ATE496533T1 (de) | 2000-07-18 | 2011-02-15 | Cornell Res Foundation Inc | Medizinische verwendung von agonisten des mu- opioid rezeptors |
| JP2002069059A (ja) * | 2000-08-28 | 2002-03-08 | Teikoku Seiyaku Co Ltd | ピラジノン環を含む新規なオピオイドペプチド誘導体 |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| US20060069086A1 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| DE102005005449A1 (de) * | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| WO2006132925A2 (en) | 2005-06-01 | 2006-12-14 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy |
| EP1782819A1 (en) | 2005-11-03 | 2007-05-09 | Cognis IP Management GmbH | Oligopeptides and their use |
| JP5244810B2 (ja) | 2006-11-10 | 2013-07-24 | カラ セラピューティクス インコーポレイテッド | 合成ペプチドアミド |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
| US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| TWI454288B (zh) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
| ES2599031T3 (es) * | 2008-05-09 | 2017-01-31 | Grünenthal GmbH | Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización |
| ES2534908T3 (es) | 2009-07-22 | 2015-04-30 | Grünenthal GmbH | Forma de dosificación de liberación controlada extruida por fusión en caliente |
| BR112012001466A2 (pt) * | 2009-07-22 | 2020-08-11 | Grünenthal GmbH | forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem |
| US9579285B2 (en) * | 2010-02-03 | 2017-02-28 | Gruenenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of an extruder |
| US20160176930A1 (en) | 2010-07-09 | 2016-06-23 | The Administrators Of The Tulane Educational Fund | Mu opioid receptor agonist analogs of the endomorphins |
| WO2012028318A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising an anionic polymer |
| CA2808219C (en) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
| JP6063462B2 (ja) | 2011-07-29 | 2017-01-18 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時薬剤放出を提供するタンパーレジスタント錠剤 |
| BR112014002022A2 (pt) | 2011-07-29 | 2017-02-21 | Gruenenthal Gmbh | comprimido resistente à violação proporcionando liberação de fármaco imediata |
| BR112014019988A8 (pt) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico |
| LT2838512T (lt) | 2012-04-18 | 2018-11-12 | GrĆ¼nenthal GmbH | Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| CN102964279B (zh) * | 2012-12-12 | 2014-05-07 | 中国药科大学 | 一类具有外周镇痛作用的κ阿片受体激动剂 |
| MX2015016254A (es) | 2013-05-29 | 2016-04-20 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal. |
| AU2014273227B2 (en) | 2013-05-29 | 2019-08-15 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
| AU2014289187B2 (en) | 2013-07-12 | 2019-07-11 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
| HK1224189A1 (zh) | 2013-11-26 | 2017-08-18 | Grünenthal GmbH | 通过低温研磨制备粉状药物组合物 |
| WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| WO2016170097A1 (en) | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| CA2998259A1 (en) | 2015-09-10 | 2017-03-16 | Grunenthal Gmbh | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG64368A1 (en) | 1988-06-30 | 1999-04-27 | Astra Ab | Dermorphin analogs their methods of preparation pharmaceutical compositions and methods of therapeutic treatment using the same |
| DK0644772T3 (da) * | 1992-11-12 | 2003-06-30 | Sod Conseils Rech Applic | Opioid-peptider |
| SE9300012D0 (sv) * | 1993-01-05 | 1993-01-05 | Astra Ab | New peptides |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
-
1995
- 1995-11-07 SE SE9503924A patent/SE9503924D0/xx unknown
-
1996
- 1996-08-06 AR ARP960103900A patent/AR003475A1/es active IP Right Grant
- 1996-08-14 DK DK96927978T patent/DK0845003T3/da active
- 1996-08-14 EE EE9800048A patent/EE9800048A/xx unknown
- 1996-08-14 TR TR1998/00258T patent/TR199800258T1/xx unknown
- 1996-08-14 NZ NZ315809A patent/NZ315809A/xx unknown
- 1996-08-14 IL IL12325896A patent/IL123258A/xx not_active IP Right Cessation
- 1996-08-14 US US08/718,585 patent/US6337319B1/en not_active Expired - Fee Related
- 1996-08-14 CN CN96197625A patent/CN1200127A/zh active Pending
- 1996-08-14 SK SK203-98A patent/SK282469B6/sk unknown
- 1996-08-14 WO PCT/SE1996/001011 patent/WO1997007130A1/en not_active Ceased
- 1996-08-14 ES ES96927978T patent/ES2171224T3/es not_active Expired - Lifetime
- 1996-08-14 AT AT96927978T patent/ATE210148T1/de not_active IP Right Cessation
- 1996-08-14 PL PL96325113A patent/PL325113A1/xx unknown
- 1996-08-14 AU AU67600/96A patent/AU711862B2/en not_active Ceased
- 1996-08-14 CA CA002229797A patent/CA2229797A1/en not_active Abandoned
- 1996-08-14 EP EP96927978A patent/EP0845003B1/en not_active Expired - Lifetime
- 1996-08-14 DE DE69617699T patent/DE69617699T2/de not_active Expired - Fee Related
- 1996-08-14 HU HU9901209A patent/HUP9901209A3/hu unknown
- 1996-08-14 JP JP9509209A patent/JPH11512086A/ja active Pending
- 1996-08-14 BR BR9610248A patent/BR9610248A/pt unknown
- 1996-08-14 CZ CZ1998401A patent/CZ287299B6/cs not_active IP Right Cessation
- 1996-08-14 RU RU98104253/04A patent/RU2165432C2/ru active
- 1996-08-14 KR KR1019980701156A patent/KR19990037677A/ko not_active Ceased
- 1996-08-15 TW TW085109918A patent/TW424095B/zh not_active IP Right Cessation
-
1998
- 1998-02-04 IS IS4664A patent/IS4664A/is unknown
- 1998-02-11 NO NO980592A patent/NO980592L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR003475A1 (es) | 1998-08-05 |
| NO980592D0 (no) | 1998-02-11 |
| RU2165432C2 (ru) | 2001-04-20 |
| ES2171224T3 (es) | 2002-09-01 |
| DE69617699D1 (de) | 2002-01-17 |
| DE69617699T2 (de) | 2003-08-07 |
| SK282469B6 (sk) | 2002-02-05 |
| CA2229797A1 (en) | 1997-02-27 |
| AU711862B2 (en) | 1999-10-21 |
| CZ40198A3 (cs) | 1998-08-12 |
| HUP9901209A3 (en) | 2000-12-28 |
| ATE210148T1 (de) | 2001-12-15 |
| EP0845003A1 (en) | 1998-06-03 |
| DK0845003T3 (da) | 2002-07-15 |
| JPH11512086A (ja) | 1999-10-19 |
| CZ287299B6 (en) | 2000-10-11 |
| EP0845003B1 (en) | 2001-12-05 |
| TR199800258T1 (xx) | 1998-05-21 |
| NZ315809A (en) | 1999-05-28 |
| SK20398A3 (en) | 1998-12-02 |
| IL123258A0 (en) | 1998-09-24 |
| TW424095B (en) | 2001-03-01 |
| EE9800048A (et) | 1998-08-17 |
| HUP9901209A2 (hu) | 1999-08-30 |
| KR19990037677A (ko) | 1999-05-25 |
| CN1200127A (zh) | 1998-11-25 |
| BR9610248A (pt) | 1999-07-06 |
| AU6760096A (en) | 1997-03-12 |
| NO980592L (no) | 1998-02-11 |
| SE9503924D0 (sv) | 1995-11-07 |
| PL325113A1 (en) | 1998-07-06 |
| US6337319B1 (en) | 2002-01-08 |
| WO1997007130A1 (en) | 1997-02-27 |
| IS4664A (is) | 1998-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116211A0 (en) | Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof | |
| IL115484A0 (en) | Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
| HU9601698D0 (en) | Pharmaceutical composition | |
| IL106600A (en) | Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof | |
| HUP9901209A3 (en) | Opioid-like peptide compounds, process for producing them and pharmaceutical compositions containing them | |
| HUP9900346A3 (en) | Endoparasiticidal pharmaceutical compositions containing avermectines and depsipeptides | |
| IL136937A0 (en) | τ-GLUTAMYL AND β-ASPARTYL CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| IL128058A0 (en) | Illudin analogs and pharmaceutical compositions containing the same | |
| IL114407A0 (en) | Novel peptides and pharmaceutical compositions comprising them | |
| ZA962214B (en) | Pharmaceutical composition | |
| ZA963590B (en) | Pharmaceutical composition | |
| IL114673A0 (en) | Pharmaceutical compositions containing protein | |
| GB9504761D0 (en) | Amphiphilic peptide and analogs thereof | |
| IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof | |
| GB9525194D0 (en) | Pharmaceutical composition | |
| ZA961051B (en) | Pharmaceutical composition | |
| IL117618A0 (en) | Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same | |
| ZA968616B (en) | Pharmaceutical composition | |
| IL117155A0 (en) | Quinolizinone derivatives and pharmaceutical compositions containing the same | |
| IL116976A0 (en) | Synthetic peptides and pharmaceutical compositions comprising them | |
| IL112094A0 (en) | Novel peptides and pharmaceutical compositions comprising them | |
| IL119412A0 (en) | Gonadotropins and pharmaceutical compositions containing them | |
| HU00563A9 (en) | Pharmaceutical bacteriocin compositions and methods for using the same | |
| HU00561A9 (en) | Pharmaceutical bacteriocin compositions and methods for using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |